Creative Biolabs Supercharges Stem Cell Therapy Development by Genome Editing Technologies

New York, United States – April 21, 2022 /MarketersMEDIA/ —

Due to impressive pluripotency and the ability to self-replicate, stem cells have been considered promising candidates for tissue engineering, cell-based diagnosis, disease modeling, and most importantly, organ regeneration. Though great progress has been made in gene and cell therapies against various diseases and cancers, scientists are still facing grand challenges in many ways, including the need for disease-specific models and more efficient gene-editing tool delivery techniques.

As a cell and gene therapy biotechnology company focusing on boosting the development of stem cell therapy, Creative Biolabs has established a wide range of cell therapy development platforms integrated with a broad array of genome editing methods.

Cutting-edge Genome Editing Technologies

Genome editing is the process of leveraging “molecular scissor” proteins to remove, replace, or add a piece of DNA in any cell, such as plant, animal, yeast, and bacteria. To address problems caused by out-of-date DNA editing technologies, several time-effective and precise genome editing technologies have been introduced. State-of-the-art techniques, such as the CRISPR/Cas9 technology and TALEN technology, have enabled Creative Biolabs to streamline a series of stem cell genome editing services to support the development of stem cells for human disease modeling.

Therapy Development Based on Stem Cells

Stems cells could be classified into embryonic stem cells (ESCs) isolated from the inner cell mass of blastocysts and induced pluripotent stem cells (iPSCs) derived from somatic tissues. Creative Biolabs can perform induced pluripotent stem cell reprogramming by viruses, episomal vectors, proteins, and mRNAs to manipulate somatic cells back to a pluripotent state for further application in regenerative medicine. Thus, stem cells have the potential for novel therapy development to replace lost or damaged cells or change the behavior of other cells.

Taking advantage of diverse features of stem cells, Creative Biolabs proposes comprehensive services for stem cell therapy development, including disease-specific stem cell therapy, iPSC-derived stem cell therapy, and iPSC-derived immune cell therapy.

“Stem cells play an important role in the development, growth, maintenance, and repair of brains, bones, muscles, nerves, blood, skin, and other organs. We have noticed the high and growing demand on stem cell therapy, so we are using stem cells for customized disease modeling to help new drugs discovery”. A stem cell researcher at Creative Biolabs said.

About Creative Biolabs

Creative Biolabs is a cell and gene therapy biotechnology company, aiming at promoting the research and development of cell and gene therapies. It has assembled industry-leading talent, been equipped with advanced facilities, and established diverse technology platforms necessary for the rapid development of cell, gene, and regenerative therapies. Focusing on providing high-quality services for stem cell research and building a long-term, reliable relationship with customers, Creative Biolabs is redefining and restating the supportive role of a biotech company in the drug development field, especially in the development of stem cell therapy.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/stem-cell-therapy/

Release ID: 89073599

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.